285 related articles for article (PubMed ID: 14582565)
21. Bacteremia in patients with hematologic malignancies.
Wang FD; Liu YM; Liu CY
J Formos Med Assoc; 1998 Jun; 97(6):405-9. PubMed ID: 9650469
[TBL] [Abstract][Full Text] [Related]
22. Risk factors and outcome of Pseudomonas aeruginosa bacteremia among adults visiting the ED.
Lee CC; Lee CH; Hong MY
Am J Emerg Med; 2012 Jul; 30(6):852-60. PubMed ID: 21855263
[TBL] [Abstract][Full Text] [Related]
23. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
[TBL] [Abstract][Full Text] [Related]
24. Health-care associated bacteremia in geriatric cancer patients with febrile neutropenia.
Aydemir H; Piskin N; Kokturk F; Gökmen A; Akduman D
J Geriatr Oncol; 2013 Apr; 4(2):190-5. PubMed ID: 24071544
[TBL] [Abstract][Full Text] [Related]
25. Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia.
Baskaran ND; Gan GG; Adeeba K; Sam IC
Int J Infect Dis; 2007 Nov; 11(6):513-7. PubMed ID: 17459753
[TBL] [Abstract][Full Text] [Related]
26. Impact of neutropenia on the clinical outcomes of Staphylococcus aureus bacteremia in patients with hematologic malignancies: a 10-year experience in a tertiary care hospital.
Ryu BH; Lee SC; Kim M; Eom Y; Jung J; Kim MJ; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):937-943. PubMed ID: 31925572
[TBL] [Abstract][Full Text] [Related]
27. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
28. Bacteremia in children at a regional hospital in Trinidad.
Orrett FA; Changoor E
Int J Infect Dis; 2007 Mar; 11(2):145-51. PubMed ID: 16787754
[TBL] [Abstract][Full Text] [Related]
29. Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.
Alali M; David MZ; Danziger-Isakov LA; Elmuti L; Bhagat PH; Bartlett AH
J Pediatr Hematol Oncol; 2020 Aug; 42(6):e445-e451. PubMed ID: 32404688
[TBL] [Abstract][Full Text] [Related]
30. Bloodstream infections in febrile neutropenic patients: bacterial spectrum and antimicrobial susceptibility pattern.
Butt T; Afzal RK; Ahmad RN; Salman M; Mahmood A; Anwar M
J Ayub Med Coll Abbottabad; 2004; 16(1):18-22. PubMed ID: 15125174
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of febrile, nonneutropenic pediatric oncology patients with central venous catheters who are not given empiric antibiotics.
Bartholomew F; Aftandilian C; Andrews J; Gutierrez K; Luna-Fineman S; Jeng M
J Pediatr; 2015 Jan; 166(1):157-62. PubMed ID: 25444524
[TBL] [Abstract][Full Text] [Related]
32. Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
Cumpston A; Craig M; Hamadani M; Abraham J; Hobbs GR; Sarwari AR
Transpl Infect Dis; 2013 Apr; 15(2):142-9. PubMed ID: 23279656
[TBL] [Abstract][Full Text] [Related]
33. Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 consecutive neutropenic patients with hematologic malignancies.
Todeschini G; Franchini M; Tecchio C; Meneghini V; Pizzolo G; Veneri D; Murari C; Ricetti MM; Perona G
Int J Infect Dis; 1998-1999 Winter; 3(2):99-104. PubMed ID: 10225988
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of hospitalized neutropenic oncology patients with Pseudomonas aeruginosa bloodstream infections: focus on oral fluoroquinolone conversion.
Yan LZ; Herrington JD
J Oncol Pharm Pract; 2016 Aug; 22(4):584-90. PubMed ID: 26156260
[TBL] [Abstract][Full Text] [Related]
35. The changing epidemiology of bacteremia in neutropenic children with cancer.
Aquino VM; Pappo A; Buchanan GR; Tkaczewski I; Mustafa MM
Pediatr Infect Dis J; 1995 Feb; 14(2):140-3. PubMed ID: 7746697
[TBL] [Abstract][Full Text] [Related]
36. Antibiotic resistance is associated with longer bacteremic episodes and worse outcome in febrile neutropenic children with cancer.
El-Mahallawy HA; El-Wakil M; Moneer MM; Shalaby L
Pediatr Blood Cancer; 2011 Aug; 57(2):283-8. PubMed ID: 21671364
[TBL] [Abstract][Full Text] [Related]
37. No association between protein C levels and bacteremia in children with febrile neutropenia.
Kassam A; Chan AK; Dzolganovski B; Constantin J; Ramphal R; Grant R; Sung L
J Pediatr Hematol Oncol; 2009 Sep; 31(9):647-50. PubMed ID: 19644401
[TBL] [Abstract][Full Text] [Related]
38. Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Wang SS; Lee NY; Hsueh PR; Huang WH; Tsui KC; Lee HC; Wu CJ; Chang CM; Huang CC; Huang CF; Ko WC
J Microbiol Immunol Infect; 2011 Aug; 44(4):282-8. PubMed ID: 21524962
[TBL] [Abstract][Full Text] [Related]
39. Isolated pathogens and clinical outcomes of adult bacteremia in the emergency department: a retrospective study in a tertiary Referral Center.
Kao CH; Kuo YC; Chen CC; Chang YT; Chen YS; Wann SR; Liu YC
J Microbiol Immunol Infect; 2011 Jun; 44(3):215-21. PubMed ID: 21524617
[TBL] [Abstract][Full Text] [Related]
40. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
